Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 1;219(1):59-67.
doi: 10.1093/infdis/jiy477.

Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness

Affiliations

Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness

Natalie I Mazur et al. J Infect Dis. .

Abstract

Background: Transplacental respiratory syncytial virus (RSV) antibody transfer has been characterized, but little is known about the protective effect of breast milk RSV-specific antibodies. Serum antibodies against the prefusion RSV fusion protein (pre-F) exhibit high neutralizing activity. We investigate protection of breast milk pre-F antibodies against RSV acute respiratory infection (ARI).

Methods: Breast milk at 1, 3, and 6 months postpartum and midnasal swabs during infant illness episodes were collected in mother-infant pairs in Nepal. One hundred seventy-four infants with and without RSV ARI were matched 1:1 by risk factors for RSV ARI. Pre-F immunoglobulin A (IgA) and immunoglobulin G (IgG) antibody levels were measured in breast milk.

Results: The median breast milk pre-F IgG antibody concentration before illness was lower in mothers of infants with RSV ARI (1.4 [interquartile range {IQR}, 1.1-1.6] log10 ng/mL) than without RSV ARI (1.5 [IQR, 1.3-1.8] log10 ng/mL) (P = .001). There was no difference in median maternal pre-F IgA antibody concentrations in cases vs controls (1.7 [IQR, 0.0-2.2] log10 ng/mL vs 1.7 [IQR, 1.2-2.2] log10 ng/mL, respectively; P = .58).

Conclusions: Low breast milk pre-F IgG antibodies before RSV ARI support a potential role for pre-F IgG as a correlate of protection against RSV ARI. Induction of breast milk pre-F IgG may be a mechanism of protection for maternal RSV vaccines.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Prefusion F (pre-F) antibody titers prior to time of infection in cases (respiratory syncytial virus positive [RSV+]) and matched controls (respiratory syncytial virus negative [RSV–]). Mann–Whitney test was performed to compare medians of cases and controls. Pre-F antibody titer was compared for measurement prior to infection. For healthy controls, antibody measurement at time of infection for age-matched cases was used. Ratio of pre-F immunoglobulin A (IgA) to total IgA (TIgA) was multiplied by 1 × 106 to ensure values on the y-axis were >0. Ratio of pre-F immunoglobulin G (IgG) and total IgG (TIgG) was multiplied by 1 × 104 for the same reason. A, Log10 pre-F IgG. B, Log10 pre-F IgA. C, Log10 pre-F IgG divided by log10 TIgG. D, Log10 pre-F IgA divided by log10 TIgA.
Figure 2.
Figure 2.
Mixed-model analysis of prefusion F (pre-F) antibody in cases and controls over time. A linear mixed-model analysis was used to examine the effect of respiratory syncytial virus (RSV) on pre-F antibodies at different time points. A, Log10 pre-F immunoglobulin G (IgG) antibody concentration at 1, 3, and 6 months postpartum for cases (RSV positive [RSV+], dark blue) and controls (RSV negative [RSV–], light blue), with medians indicated in black. B, Linear mixed-model analysis for log10 pre-F IgG in cases and controls. Solid line is the mean, and dashed line indicates the 95% confidence interval (CI). C, Log10 pre-F immunoglobulin A (IgA) antibody concentration at 1, 3, and 6 months postpartum for cases and controls, with medians in black. D, Linear mixed-model analysis for log10 pre-F IgA in cases and controls. Solid line is the mean, and dashed line indicates the 95% CI.

Similar articles

Cited by

References

    1. Omer SB. Maternal immunization. N Engl J Med 2017; 376:1256–67. - PubMed
    1. Chu HY, Steinhoff MC, Magaret A, et al. . Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh. J Infect Dis 2014; 210:1582–9. - PMC - PubMed
    1. Ochola R, Sande C, Fegan G, et al. . The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya. PLoS One 2009; 4:e8088. - PMC - PubMed
    1. Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 2003; 21:3465–7. - PubMed
    1. Suara RO, Piedra PA, Glezen WP, et al. . Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in The Gambia and in the United States. Clin Diagn Lab Immunol 1996; 3:477–9. - PMC - PubMed

Publication types

MeSH terms